Furthermore, immune checkpoint analysis revealed a correlation between PITX1 expression and expression of pivotal immune checkpoint genes across various cancer types (Figure 5D), indicating that PITX1 could serve as a promising diagnostic marker for immunotherapy. The gene discussed is PITX1; the disease is cancer.